![Andrew Paul Mercieca](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Andrew Paul Mercieca
Directeur/Membre du Conseil chez
Octant Ltd.
Profil
Andrew Paul Mercieca currently works at Octant Ltd., as Director.
Mr. Mercieca also formerly worked at Strategic Partners A, as Independent Director in 2022 and Autolus Therapeutics Plc, as Chief Accounting Officer & Vice President-Finance.
Mr. Mercieca received his undergraduate degree from the University of Portsmouth.
Postes actifs de Andrew Paul Mercieca
| Sociétés | Poste | Début |
|---|---|---|
Octant Ltd. | Directeur/Membre du Conseil | - |
Anciens postes connus de Andrew Paul Mercieca
| Sociétés | Poste | Fin |
|---|---|---|
| AUTOLUS THERAPEUTICS PLC | Comptroller/Controller/Auditor | 03/04/2025 |
| STRATEGIC PARTNERS A/S | Directeur/Membre du Conseil | 29/06/2022 |
Formation de Andrew Paul Mercieca
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
2
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
University of Portsmouth
 University of Portsmouth Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Strategic Partners A/S
 Strategic Partners A/S Pharmaceuticals: MajorHealth Technology Provides therapeutic treatment of of diseases caused by defects in the function and metabolism of proteins | Health Technology |
Octant Ltd. | |
Autolus Therapeutics Plc
 Autolus Therapeutics Plc Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of gene therapies | Health Technology |
